Trial Outcomes & Findings for Picosure Alexandrite Laser for the Treatment of Unwanted Tattoos (NCT NCT02110095)

NCT ID: NCT02110095

Last Updated: 2020-12-11

Results Overview

Tattoo clearance will be measured using baseline and 2 month post treatment photos using a photographic scale. The scale ranges from 0 to 10, where 10 is 100% improvement from the baseline photo.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

15 participants

Primary outcome timeframe

2 months post last treatment

Results posted on

2020-12-11

Participant Flow

Participant milestones

Participant milestones
Measure
Picosure Laser System
Picosure Laser System for the treatment of unwanted tattoos Picosure Laser System: Picosure Laser System for the Treatment of Unwanted Tattoos
Overall Study
STARTED
15
Overall Study
COMPLETED
8
Overall Study
NOT COMPLETED
7

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

One of the subjects did not report his/her race/ethnicity.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Picosure Laser System
n=15 Participants
Picosure Laser System for the treatment of unwanted tattoos Picosure Laser System: Picosure Laser System for the Treatment of Unwanted Tattoos
Age, Categorical
<=18 years
0 Participants
n=15 Participants
Age, Categorical
Between 18 and 65 years
15 Participants
n=15 Participants
Age, Categorical
>=65 years
0 Participants
n=15 Participants
Sex: Female, Male
Female
9 Participants
n=15 Participants
Sex: Female, Male
Male
6 Participants
n=15 Participants
Race/Ethnicity, Customized
Race/Ethnicity · Caucasian
10 Participants
n=14 Participants • One of the subjects did not report his/her race/ethnicity.
Race/Ethnicity, Customized
Race/Ethnicity · African American
3 Participants
n=14 Participants • One of the subjects did not report his/her race/ethnicity.
Race/Ethnicity, Customized
Race/Ethnicity · Asian
1 Participants
n=14 Participants • One of the subjects did not report his/her race/ethnicity.
Race/Ethnicity, Customized
Race/Ethnicity · Indian
0 Participants
n=14 Participants • One of the subjects did not report his/her race/ethnicity.
Race/Ethnicity, Customized
Race/Ethnicity · Hispanic
0 Participants
n=14 Participants • One of the subjects did not report his/her race/ethnicity.
Fitzpatrick Skin Type
Fitzpatrick Skin Type I
2 Participants
n=15 Participants
Fitzpatrick Skin Type
Fitzpatrick Skin Type II
5 Participants
n=15 Participants
Fitzpatrick Skin Type
Fitzpatrick Skin Type III
4 Participants
n=15 Participants
Fitzpatrick Skin Type
Fitzpatrick Skin Type IV
0 Participants
n=15 Participants
Fitzpatrick Skin Type
Fitzpatrick Skin Type V
3 Participants
n=15 Participants
Fitzpatrick Skin Type
Fitzpatrick Skin Type VI
1 Participants
n=15 Participants

PRIMARY outcome

Timeframe: 2 months post last treatment

Tattoo clearance will be measured using baseline and 2 month post treatment photos using a photographic scale. The scale ranges from 0 to 10, where 10 is 100% improvement from the baseline photo.

Outcome measures

Outcome measures
Measure
Picosure Laser System
n=8 Participants
Picosure Laser System for the treatment of unwanted tattoos Picosure Laser System: Picosure Laser System for the Treatment of Unwanted Tattoos
Number of Patients With Tattoo Clearance
# of Patients with 20% Improvement
3 Participants
Number of Patients With Tattoo Clearance
# of Patients with 30% Improvement
5 Participants

SECONDARY outcome

Timeframe: 2 months post last treatment

This measures the physician satisfaction from 1 to 5, where 5 is the most satisfied.

Outcome measures

Outcome measures
Measure
Picosure Laser System
n=8 Participants
Picosure Laser System for the treatment of unwanted tattoos Picosure Laser System: Picosure Laser System for the Treatment of Unwanted Tattoos
Physician Satisfaction Questionnaire
Patients scored a 5 by physician
4 Participants
Physician Satisfaction Questionnaire
Patients scored a 4 by Physician
4 Participants

Adverse Events

Picosure Laser System

Serious events: 0 serious events
Other events: 15 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Picosure Laser System
n=15 participants at risk
Picosure Laser System for the treatment of unwanted tattoos Picosure Laser System: Picosure Laser System for the Treatment of Unwanted Tattoos
Nervous system disorders
Pain
53.3%
8/15 • Adverse events were collected for the study duration, around 19 months.
Skin and subcutaneous tissue disorders
Blistering
46.7%
7/15 • Adverse events were collected for the study duration, around 19 months.
Skin and subcutaneous tissue disorders
Erythema
33.3%
5/15 • Adverse events were collected for the study duration, around 19 months.
Skin and subcutaneous tissue disorders
Edema
26.7%
4/15 • Adverse events were collected for the study duration, around 19 months.
Skin and subcutaneous tissue disorders
Bruising
6.7%
1/15 • Adverse events were collected for the study duration, around 19 months.
Skin and subcutaneous tissue disorders
Pinpoint Bleeding
26.7%
4/15 • Adverse events were collected for the study duration, around 19 months.
Skin and subcutaneous tissue disorders
Crusting
73.3%
11/15 • Adverse events were collected for the study duration, around 19 months.
Skin and subcutaneous tissue disorders
Itching
53.3%
8/15 • Adverse events were collected for the study duration, around 19 months.
Skin and subcutaneous tissue disorders
Allergic Reaction
13.3%
2/15 • Adverse events were collected for the study duration, around 19 months.
Skin and subcutaneous tissue disorders
Hypopigmentation
13.3%
2/15 • Adverse events were collected for the study duration, around 19 months.

Additional Information

Jamie Trimper

Cynosure

Phone: 800-886-2966

Results disclosure agreements

  • Principal investigator is a sponsor employee The PI cannot disclose confidential or proprietary information until after it becomes generally known or available to the public.
  • Publication restrictions are in place

Restriction type: OTHER